Clinical Trial Update: Continuous Delivery of Levodopa in Patients With Advanced Idiopathic Parkinsons Disease - Cost-benefit [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the cost-benefit of continuous levodopa delivery in advanced Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Levodopa (continuous delivery) (levodopa)

Snippet

Sponsor: University Hospital, Akershus | Conditions: Parkinson Disease | Phase 4 | Status: COMPLETED